Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19020245.
- Also identified by DOI 10.2214/AJR.07.3431.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of our study was to show the efficacy and safety of percutaneous ethanol ablation in managing recurrent primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1 (MEN1) after subtotal parathyroidectomy. Ethanol ablation is a viable alternative to reoperation for the management of recurrent primary hyperparathyroidism in patients with MEN1.
Medical subject headings
- Ethanol
- Hyperparathyroidism
- Multiple Endocrine Neoplasia Type 1
- Neoplasm Recurrence, Local
- Parathyroid Neoplasms